Prospect News: News for Silica SAS

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with S > Issuers starting with S, BK only > All stories on Silica SAS > Stories on Silica SAS, BK only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Silica SAS

9/12/2025	BK	SGD Pharma sets €580 million of term debt at Euribor plus 350 bps
9/11/2025	BK	SGD Pharma revises add-on term loan size, talk, adds amend and extend
9/8/2025	BK	SGD Pharma launches €70 million add-on term loan at 99.75-par OID
5/2/2024	BK	Moody’s views SGD Pharma positively
7/20/2022	BK	Moody's downgrades SGD Pharma
7/20/2021	BK	Moody's gives SGD Pharma B2
7/20/2021	BK	S&P rates SGD Pharma, loans B

©2026 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.